Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: GSK-(GlaxoSmithKline)

GSK-RESULTS/
RTSABCZ1 
August 10, 2022 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-RESULTS/
RTSABCYZ 
August 10, 2022 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-RESULTS/
RTSABCYY 
August 10, 2022 
GSK (GlaxoSmithKline) logo and rising stock graph are seen in this illustration, August 10, 2022. REUTERS/Dado... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo and rising stock graph 
GSK (GlaxoSmithKline) logo and rising stock graph are seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-RESULTS/
RTSABCXH 
August 10, 2022 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-M&A/UNILEVER
RTS4LL6U 
January 17, 2022 
A detail view of the exterior of the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah... 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
A detail view of the exterior of the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LL5J 
January 17, 2022 
A London Black Cab passes the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah... 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
A London Black Cab passes the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LL45 
January 17, 2022 
People walk past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
People walk past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LL43 
January 17, 2022 
A person walks past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay... 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
A person walks past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER-CONSUMER HEALTH
RTS4LJPP 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFS 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFT 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFU 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFV 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
HEALTH-CORONAVIRUS/FRANCE-ICU
RTXBZY7A 
May 04, 2021 
GlaxoSmithKline's (GSK) drug, Augmentin, is seen in the COVID-19 Intensive Care Unit (ICU) at the Centre... 
Saint-Denis, France 
Intensive care unit at the Centre Cardiologique du Nord private hospital in Saint-Denis near Paris 
GlaxoSmithKline's (GSK) drug, Augmentin, is seen in the COVID-19 Intensive Care Unit (ICU) at the Centre Cardiologique du Nord private hospital in Saint-Denis, near Paris, amid the coronavirus disease pandemic in France, May 4, 2021. REUTERS/Benoit Tessier 
CHINA-TRADE/EXPO
RTX87CCX 
November 05, 2020 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China... 
Shanghai, China 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song 
CHINA-TRADE/EXPO
RTX87CCV 
November 05, 2020 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China... 
Shanghai, China 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song 
CHINA-TRADE/EXPO
RTX87CCP 
November 05, 2020 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China... 
Shanghai, China 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song 
GSK-RESULTS/
RTX855HV 
October 26, 2020 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October... 
STEVENAGE, United Kingdom 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs 
GSK-RESULTS/
RTX855HN 
October 26, 2020 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October... 
STEVENAGE, United Kingdom 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs 
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O6 
May 04, 2020 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs 
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O4 
May 04, 2020 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs 
GSK-RESULTS/
RTX7AKVN 
November 26, 2019 
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline... 
STEVENAGE, United Kingdom 
A scientist studies cancer cells inside white blood cells through a microscope at the GSK research centre... 
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKVJ 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKVG 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKVA 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV9 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV7 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV6 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV5 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV4 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV3 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV2 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV1 
November 26, 2019 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKUX 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKUR 
November 26, 2019 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKUP 
November 26, 2019 
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November... 
STEVENAGE, United Kingdom 
A GSK logo is seen on a flag at a GSK research centre in Stevenage 
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKSX 
November 26, 2019 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019.... 
STEVENAGE, United Kingdom 
A GSK logo is seen at the GSK research centre in Stevenage 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKSP 
November 26, 2019 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019.... 
STEVENAGE, United Kingdom 
A GSK logo is seen at the GSK research centre in Stevenage 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
BRITAIN-EU/
RTX6G1C7 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1BS 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1BP 
October 22, 2018 
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland,... 
MONTROSE, United Kingdom 
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland... 
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1BK 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1BD 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1BB 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
SINGAPORE-PHARMACEUTICALS/
RTX5CFOE 
March 25, 2018 
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken... 
Singapore, Singapore 
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore 
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFO9 
March 25, 2018 
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken... 
Singapore, Singapore 
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore 
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFNY 
March 25, 2018 
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture... 
Singapore, Singapore 
The GSK logo is seen on top of GSK Asia House in Singapore 
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFNU 
March 25, 2018 
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture... 
Singapore, Singapore 
The GSK logo is seen on top of GSK Asia House in Singapore 
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFNQ 
March 25, 2018 
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken... 
Singapore, Singapore 
An aerial view of GSK Asia House is seen in Singapore 
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFNM 
March 25, 2018 
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken... 
Singapore, Singapore 
A SMRT train travels past GSK Asia House in Singapore 
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFMP 
March 25, 2018 
The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore,... 
Singapore, Singapore 
The GSK logo on the facade of GSK Asia House is seen through vertical louvres in Singapore 
The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFMD 
March 25, 2018 
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture... 
Singapore, Singapore 
The GSK logo is seen on top of GSK Asia House in Singapore 
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFM9 
March 25, 2018 
An exterior view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken... 
Singapore, Singapore 
An exterior view of GSK Asia House is seen in Singapore 
An exterior view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
SINGAPORE-PHARMACEUTICALS/
RTX5CFM6 
March 25, 2018 
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken... 
Singapore, Singapore 
An aerial view of GSK Asia House is seen in Singapore 
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera 
GSK-CEO/
RTX3ICS3 
October 26, 2017 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London,... 
London, United Kingdom 
GlaxoSmithKline CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain, October 9, 2017. Picture taken October 9, 2017. REUTERS/Toby Melville 
BRITAIN-EU/BUSINESS
RTS1FQOY 
October 09, 2017 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing... 
London, United Kingdom 
GlaxoSmithKline CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing... 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville 
BRITAIN-EU/BUSINESS
RTS1FQJZ 
October 09, 2017 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street... 
London, United Kingdom 
GlaxoSmithKline CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street... 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville 
BRITAIN-EU/BUSINESS
RTS1FQJW 
October 09, 2017 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London,... 
London, United Kingdom 
GlaxoSmithKline CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London 
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville 
GSK-ADVAIR/ C
RTX2FIAJ 
June 03, 2016 
GlaxoSmithKline’s top-selling lung drug Advair is now facing generic competition after the drug lost... 
Rise and fall of Advair EPS C 
GlaxoSmithKline’s top-selling lung drug Advair is now facing generic competition after the drug lost patent protection. 
GSK-MOVES/CEO
RTX2CX1R 
May 05, 2016 
The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. REUTERS/Luke... 
London, United Kingdom 
The GlaxoSmithKline building in Hounslow, west London 
The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. REUTERS/Luke MacGregor/File Photo 
Sort by 
Display 
Items per page 
Page 
of 3